From a clinical perspective, a diagnosis of Br-NET, despite the term tumor, implies an identical treatment to any BC of comparable grade, stage, and hormonal profile, being most Br-NETs estrogen (ER) and progesterone (PgR) receptor positive. Here, PGR is linked to neoplasm.